Published on in Vol 5, No 2 (2017): February
Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia
Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia
Altmetric
Altmetric discovers Social Media mentions. Click the ‘See more details’ link for a full report.
Dimensions
Dimensions discovers Citations. Click the ‘details’ link for a full report.